A post-hoc analysis of the REDEFINE 1 trial suggests that the investigational cagrilintide-semaglutide combination (CagriSema ...

At 48 weeks, participants receiving the highest dose combination of 9 mg eloralintide and 15 mg tirzepatide achieved an ...

Pharmacists are moving well beyond the dispensing counter and are taking on active roles in managing patients alongside ...

Viral pathogens are increasingly recognized in up to 26% of adult CAP hospitalizations, with influenza and RSV historically ...

Pharmacy benefit manager (PBM) reform is gaining momentum nationwide, but experts caution that pharmacies, a cornerstone of ...

Similarly, a large cross-sectional study in China evaluating individuals who recovered from COVID-19 found that 42.2% exhibited hesitancy toward subsequent doses, with higher levels of pandemic ...

Therapy is aimed at decreasing pathogenic IgA production and immune complex formation as well as managing the effects of ...

Throughout October, key recognition dates highlight the profession’s diverse workforce, including National Student ...

Rita King, CEO of MethodSense, provides her expertise on the integration of AI in medical devices and key developments for pharmacists as the technology evolves.

Four approved PrEP options now span daily pills and long-acting injections. The faculty review how each agent works and where ...

Brianne Porter, PharmD, MS, explores how pharmacists can deliver care to a population of women experiencing life-altering symptoms of urinary incontinence.

At eligible safety-net organizations, the 340B Drug Pricing Program may also support access. However, discounted acquisition costs do not establish a patient’s final charge. Pharmacists should confirm ...